Evaluation of clinical significance of с.2956G>A (rs112287730) polymorphism in FBN1 gene in Marfan syndrome

[1]  D. Keene,et al.  FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders. , 2016, Gene.

[2]  A. Polyakov,et al.  Clinical and genetic characteristics of Russian Marfan patients , 2015, Russian Journal of Genetics.

[3]  A. Stuenkel,et al.  The spectrum of FBN1, TGFβR1, TGFβR2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys-Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD). , 2014, Molecular genetics and metabolism.

[4]  M Claustres,et al.  Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. , 2007, American journal of human genetics.

[5]  M. Tekin,et al.  Familial neonatal Marfan syndrome due to parental mosaicism of a missense mutation in the FBN1 gene , 2007, American journal of medical genetics. Part A.

[6]  P. Robinson,et al.  The molecular genetics of Marfan syndrome and related disorders , 2006, Journal of Medical Genetics.

[7]  K. Rommel,et al.  Identification of 29 novel and nine recurrent fibrillin‐1 (FBN1) mutations and genotype–phenotype correlations in 76 patients with Marfan syndrome , 2005, Human mutation.

[8]  D. Judge,et al.  TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome , 2004 .

[9]  D. Judge,et al.  TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. , 2004, The Journal of clinical investigation.